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Abstract. The demand for donated organs greatly exceeds supply and many candidates die awaiting transplantation. Policies for allocating
deceased donor organs may address equity of access and medical efficacy, but typically must be implemented with incomplete information.
Simulation-based analysis can inform the policy process by predicting the likely effects of alternative policies on a wide variety of outcomes
of interest. This paper describes a family of simulations developed by the US Scientific Registry of Transplant Recipients and initial
experience in the application of one member of this family, the Liver Simulated Allocation Model (LSAM).
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1. Introduction
1.1. Scarcity of organs for transplantation
Allocating the scarce and precious resource of donated organs
in an equitable, effective, and efficient manner is a complex
problem. Policies are the subject of intense discussion, and
disagreement is inevitable, because the award of an organ to
one candidate denies it to others. It is critical to inform policy
deliberations with valid and objective information. Predicting
the impacts of proposed new organ allocation policies is very
difficult, because there are many factors that can change in
unpredictable ways when rules change. The types of candi-
dates on waitlists and the medical statuses of candidates and
graft recipients change over time; large numbers of patients
and organs are involved; patient and organ characteristics are
diverse; medical outcomes cannot be predicted with certainty;
and policies can produce results that may not be anticipated.
Simulation offers a practical way to represent this dynamic
system and to provide information needed for informed de-
bate before a policy change is put into effect. This paper de-
scribes a family of simulations developed for this purpose and
initial experience with one member, the Liver Simulated Al-
location Model (LSAM), in the analysis of liver allocation
policies.
The importance of the problem is illustrated by the exam-
ple of liver transplantation. For many persons with end-stage
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liver disease, a liver transplant may be the only effective ther-
apy, but every year many die because too few donor livers
are made available. In order to receive a cadaveric transplant,
candidates must register on a national waitlist and wait for an
organ to become available and be allocated to them. During
2001, 1970 people died while waiting for a liver transplant in
the United States, while 4663 cadaveric transplants and 514
transplants from living donors were performed. The number
of persons on the waitlist grew 12% to 18,214 at the end of
2001 [1]. At least 140 others died after being removed from
the waitlist because they were no longer healthy enough to
survive or benefit from a transplant or for other reasons. Al-
though liver transplantation carries some risks, over 70% of
transplant recipients (under age 65) are still alive 5 years after
liver transplantation [2].
1.2. The U.S. organ allocation system
With oversight and funding from the Department of Health
and Human Services (HHS), the Organ Procurement and
Transplantation Network (OPTN) proposes policies for organ
allocation, maintains the waitlists, implements the policies,
and collects data on transplantation. Transplant centers at
hospitals around the United States perform transplants with
organs procured from cadaveric donors by local organ pro-
curement organizations (OPOs). Patients in need of trans-
plants are entered onto the waitlist. When an organ becomes
available, the active candidates on the waitlist are ordered as
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specified by the current policy and the liver is offered to can-
didates in this order. The organ is transplanted to the first
candidate to accept the offer, and that patient is then removed
from the waitlist. Candidates are classified according to risk
of short-term mortality on the waitlist, with priority given to
those at highest risk. Methods of risk measurement have var-
ied historically as different policies have been in effect.
Specifics of allocation policies vary among different or-
gans. In the allocation of livers, for example, geography also
plays an important role. In general, ordering of candidate re-
cipients of a given donor organ occurs within three nested
sets of geographic area. Organs are first offered to candidates
who are within the service area of the donor hospital’s organ
procurement organization (OPO). Next, candidates within a
larger, usually multiple state region are considered, and then
finally the remainder of candidates in the rest of the United
States.
In February 2002, the prioritization system for non-status
1 candidates was changed from one based upon waiting time
within these broad categories of medical necessity to one
based on a scaled measure of the 90-day risk of mortality
while on the waiting list [3]. This change was motivated by
the reality of there being more patients than organs – a wait-
ing-time based system will generally result in the allocation of
organs to those patients who are healthy enough to survive un-
til they can move to the front of the waiting-time queue. Thus,
a waiting time based system fails to prevent deaths among
those at highest risk for death.
In this paper, we describe a family of simulation models
that includes the liver model and compare results to those that
actually occurred when the policy change was implemented.
Previous simulation-based studies of liver allocation policies
include Howard’s [4] analysis of sickest-patient-first policies,
a model of the liver allocation system in the United Kingdom
developed by Ratliffe et al. [5], and the United Network for
Organ Sharing (UNOS) Liver Allocation Model (ULAMSM),
developed and applied when UNOS was the contractor op-
erating the U.S. Scientific Registry of Transplant Recipients
(SRTR) [6–11].
1.3. Simulation-based analyses of organ allocation policies
The organ transplantation community faces a wide variety of
issues that can be addressed by simulation-based analyses.
Further, the prospect is that more issues will arise in the fu-
ture, as medical science and the demographics of the popula-
tion change. In response to this need, the Health Resources
and Services Administration (HRSA) of HHS decided to ac-
quire a new set of simulation tools for analysis of issues in
liver, heart, lung, kidney, and pancreas transplant allocation
policies. There was a broad need in the transplant field to
develop new allocation simulations that would:
• let investigators easily explore a wide range of policies;
• allow the simulation program to be easily rewritten and,
to some extent, let users define new policies without new
programming;
• allow several of the most detailed simulation assumptions
to be modeled externally to the program and be used as
input to the program;
• be validated against historical and future data;
• be coded in short time and not require expensive or pro-
prietary simulation software packages; and
• be available to other researchers in the organ transplant
community.
A family of three simulations was designed by the Uni-
versity Renal Research and Education Association (URREA)
with the University of Michigan, under its contract as the
current contractor for the SRTR to meet these requirements.
LSAM models the allocation of livers; the Thoracic Simu-
lated Allocation Model (TSAM) is an integrated heart and
lung allocation model; and the Kidney-Pancreas Simulated
Allocation Model (KPSAM) models the allocation of kidneys
and pancreata. The simulations are written in Object Pascal,
using Borland’s Delphi™ development environment. The re-
sulting code is portable and openly available.
2. Modeling methods
2.1. General approach
The models separate two components of the organ transplan-
tation system. One component is the environment in which an
allocation policy operates, which is defined by the stream of
patients who are on and who are added to the waitlist and by
the stream of organs that are available for transplant. A sec-
ond component consists of the policies that link the patients
to the organs that are available and the subsequent experience
of transplant recipients. These two components are logically
separable. The environment is addressed principally as an
input stream to the program while the policies are largely in-
corporated directly into the code of the program. Very broad
and flexible input specifications for the environment data are
allowed and very flexible families of policies can be imple-
mented within the framework of the programs, as described
below.
The separation between environment and allocation sys-
tem is reflected in the model structure shown in figure 1. Ar-
rivals of patients, organs, and patient status changes are gen-
erated in SAS™ and input to the allocation system model. The
general approach to modeling the allocation system is Monte
Carlo, event-sequenced simulation, coded in Object Pascal.
This model generates sequences of pseudo-random numbers
to generate realizations of random processes (e.g., organ ac-
ceptance decisions and graft survival times), and advances
time by sequencing discrete events in time order.
2.2. Candidate and organ arrivals
As shown in figure 1, each simulation has been designed to
take advantage of characteristic structures of the organ trans-
plantation and allocation system. Certain processes oper-
ate independently of the rest of the system, because there is
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Figure 1. Top-level schematic of patient and organ flows.
no feedback to them. Two of these are the donation of or-
gans and the listing of candidates for their first transplants.
These processes are represented as streams of arrivals input
to the simulation. Model users can generate arrival streams
from historical arrival data, synthetic data, reordered histori-
cal data, or combinations of these methods. In practice, we
use SAS™ to prepare input arrival records from historical and
synthetic arrival data. This allows a wide variety of environ-
ments to be evaluated with a wide variety of data sources.
The initial waitlist membership (i.e., at the starting simulated
time) is also input to the model. Arrival records specify char-
acteristics of candidates at the time of listing (age, transplant
center, etc.) and characteristics of donors and organs (blood
type, weight, etc.).
2.3. Candidate status
A time-ordered input stream describes changes to each candi-
date’s medical conditions and listing statuses that would occur
if the candidate received no transplant. Candidates’ medical
conditions may improve or deteriorate over time, and a candi-
date may die, leave the system, become temporarily inactive,
or resume active status prior to receiving a transplant. Model
users may define new patient attributes and status codes, or
use historical defaults. Patient histories can be structured to
include covariates used in survival and organ acceptance mod-
els, such as organ-specific medical status codes.
Because the time of graft offer cannot be predicted prior
to running the simulation, each candidate’s status stream de-
scribes the candidate’s entire history from the time of list-
ing until either death or the end of the simulated time period,
whichever comes first. Users can generate the status streams
synthetically or use actual historical statuses (although the
histories of actual candidates who received transplants need
to be synthetically extended to either the predicted time of
death on the waitlist or, in the absence of a transplant, the end
of the simulated time horizon). In practice, we use SAS™ to
generate status change input records from historical and syn-
thetic bases of status change data.
Provision is also made for candidates whose transplanted
organs fail and who rejoin the waitlist. A candidate’s original
input stream of status changes ceases to be relevant when the
simulation awards a graft to that candidate. For this reason,
the input stream cannot be applied to a patient who receives
a graft and later rejoins the waitlist because of a failing graft.
Instead, separate pools of status histories can be generated or
provided to the simulation, from which the simulation sam-
ples a history to assign to the relisted patient.
2.4. Organ allocation
A time ordered input stream provides the arrival time and
characteristics of donated organs. When an organ becomes
available, the simulation reorders the active candidates on the
waitlist according to the operative policy and offers the or-
gan to candidates in this order. Because donor and candidate
characteristics (e.g., blood type compatibility) are compared,
the waitlist is reordered every time a new organ is donated
(the “match process”). The organ is transplanted to the first
candidate to accept the offer.
2.5. Organ acceptance and post-graft survival
To allow for future modeling improvements, the simulations
provide flexible representations of the organ acceptance de-
cision and post-graft processes. Simulation users may define
models for such processes in terms of donor-candidate cate-
gories (strata), vectors of donor and candidate variables (X),
and a vector of coefficients of these variables (Bj ) for each
stratum (j ). Further flexibility is offered by allowing the de-
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finition of other inputs to the process models as simple al-
gebraic functions of these original inputs and of the status
history characteristics, which can change over time.
The probability of organ acceptance is modeled as a logis-
tic function of the inner product XBj . This functional form
provides considerable flexibility for representing acceptance
probabilities and their dependence on donor and organ char-
acteristics. This approach allows flexibility of application to
each organ model. The available covariates could be explored
to find a combination that best explains historical acceptance
decisions. For the acceptance decision, the model samples
a pseudo-random number and compares it to an acceptance
probability computed as a logistic function of candidate and
donor characteristics.
Acceptance of an organ leads to transplantation and re-
moval of the recipient from the waitlist. The simulation then
tracks the post-graft experience of the recipient, including the
potential for graft failure and rejoining the waitlist, and mor-
tality.
Post-graft survival is represented by a Cox proportional
risk model or a Weibull model. For the Cox proportional risk
model, the user also supplies a baseline survival function in
tabular form for each stratum. Specific covariates in the sur-
vival function depend on the organ being modeled, but in-
clude a variety of pre-defined and user-defined characteristics
of patient and organ, including measures of clinical condition
of the patient at the time of transplant. The simulation gen-
erates a survival time by sampling a pseudo-random number
and inverting the survival function. Death may be due to or-
gan failure. In LSAM and TSAM, death occurs within a few
days of organ failure unless a second transplant occurs first.
In KPSAM, there is also the possibility that the patient will
return to dialysis, which is an alternative medical treatment
for kidney failure.
Patients are randomly allowed to relist prior to the sampled
death date. The probability and time of relisting, stratified by
post-graft survival time, are input to the model. The simula-
tion adds post-graft status change events, including death or
removal from the waitlist, to the list of scheduled events.
2.6. Model boundaries
It is important to recognize that the representation of the trans-
plantation system does not stop strictly with the software,
but also includes the assumptions used in preparing inputs
to the model. This data-centered approach is prudent, given
the level of uncertainty and changing knowledge about the
nature of many of the constituent biological and behavioral
processes. However, this approach places a number of im-
portant process representations outside the boundaries of the
code and in the hands of those who prepare the input data, de-
fined in the User Manual [12]. This data-centered approach
provides the simulations with considerable flexibility, but it
also requires of users a level of acquaintance with details of
the simulation and its input data. Since future policies are
likely to involve unforeseeable clinical status measures, it is
not practical to attempt to generate all of the potential types
of complex stochastic status histories within the simulation
program. The waitlist status histories were left outside of
the simulation programs, resulting in great flexibility for user
specification of these histories.
3. Representing policies
All simulations of the family incorporate a policy description
language by which users may specify a wide variety of al-
ternative allocation policies without reprogramming the sim-
ulation. Users may describe allocation policies in text data
files and further edit and save these policies via the simula-
tion’s graphical user interface. The function of the policy de-
scription language is to specify an algorithm for ordering the
waitlist, given a donated organ of specified characteristics, in
terms of:
• criteria for screening out potential candidates for lack of
suitability (e.g., unacceptable body weight of the liver
donor);
• grouping candidates into priority classes based on com-
mon characteristics (e.g., medical urgency codes and loca-
tion relative to the donor’s OPO);
• ranking candidates within a classification based on se-
quential sorts and additive point awards (e.g., waiting time
or mortality risk score); and
• defining subgroups of priority classes (e.g., giving pedi-
atric candidates priority for a pediatric organ, or partition-
ing based on a threshold value of mortality risk).
These features can represent current and historical policies
for heart, lung, liver, kidney, and pancreas, as well as a wide
variety of alternative policies. Flexibility is enhanced by the
ability to add new, user-defined fields to input records (i.e.,
new characteristics of candidates and organs) and reference
these fields in the definition of an allocation policy. User-
defined input fields are also included in the vector of donor
and candidate variables in the organ acceptance and post-graft
survival models.
Table 1 lists an extract from an example liver allocation
policy. A policy may be divided into sections that apply to
different groups of donors, such as the example shown here
for adult donors. Within each donor group, the policy lists
categories of candidates in priority order. In this example, the
top priority category consists of candidates in medical status 1
(the most urgent cases) who are located in the same local unit
as the donor. These candidates (if any) are ranked in order
of allocation points, status 1 waiting time, and total waiting
time. (Examples of factors that can be considered in allo-
cating points are given in section 4.) If no candidate in this
category accepts the liver, the model proceeds to the next line
in the policy definition. This is only an example of the criteria
that can be used for screening and ranking.
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Table 1




















a This table demonstrates that prioritization can be based on broad ordered categories with continuous scales within each category that are specific to that
category. Note that waiting time is used to rank order status 1 candidates, while MELD score is used to prioritize non-status 1 patients.
4. Initial application of LSAM
LSAM development began in February 2001, and a prototype
was completed in June 2001. In September 2001, LSAM
version 0.9.6 (a version with “hard coded” allocation rules)
was validated against historical OPTN data and applied to a
prospective analysis of a proposed change to the OPTN liver
allocation policy incorporating the Model for End-stage Liver
Disease (MELD) disease severity index.
4.1. Current and previous policies
Until recently, medical urgency was measured through a
status-based set of medical urgency codes. In the most recent
version of this system, patients with rapid and life-threatening
liver dysfunction were classified as status 1, as were trans-
plant recipients whose graft failed within seven days. Patients
with chronic liver disease were classified into statuses 2A, 2B,
and 3, in decreasing order of severity and based largely on the
Child-Turcotte-Pugh (CTP) scale [13]. The CTP scale com-
bines the international normalized ratio (INR, a measure of
the blood’s ability to clot), the bilirubin level in the blood
(a measure of liver function), the albumin level in the blood
(a measure of nutrition), the presence of encephalopathy, and
the presence of ascites (fluid in the abdomen). The status-
based codes also recognized patients who were temporarily
inactive (status 7), patients who died while waiting for a trans-
plant (status 8), and patients who had been removed from the
waiting list (status 9).
MELD is a disease severity index, based on easily obtained
measurements of patients, which has been shown to be a re-
liable measure of mortality risk for end-stage liver disease
[14,15]. MELD eliminates the two subjective factors of the
CTP scale (encephalopathy and ascites), retains the INR and
bilirubin, and adds the creatinine level in the blood (a mea-
sure of kidney function). MELD is computed by a regression
formula as a function of a candidate’s INR, bilirubin, and cre-
atinine levels.
On February 27, 2002, the OPTN liver allocation sys-
tem started operation of a new liver allocation policy that
eliminated the former medical statuses for candidates with
chronic disease and substituted disease severity with MELD
scores [3]. Status 1 was retained as a classification for acutely
ill candidates, and all other adult patients were to be assigned
MELD scores, as measures of the three-month risk of mor-
tality of remaining on the waitlist. A related risk measure,
the Pediatric End-stage Liver Disease (PELD) score [16], was
created for pediatric candidates.
4.2. Data used
The simulation runs used actual data for all patients on the
waitlist in 1999, and simulated all activity in the period from
1/1/99 through 12/31/99. We input the actual entire history
of status changes and death dates for all patients, except for
those who received a transplant. The MELD-based runs re-
quired histories of MELD changes for all patients. These
were selected randomly from actual histories of patients in
a University of Michigan study of MELD mortality [15], sub-
ject to matching initial waitlist status and survival time. Since
the simulation does not give transplants to all patients who
were actually transplanted, it was also necessary to create ar-
tificial status change histories and death dates that extend be-
yond the actual time of transplant for these patients. Artifi-
cial death dates and status change histories were generated
from actual histories of patients in the SRTR database, sub-
ject to matching certain patient characteristics. We matched
patients on the waitlist for status histories in the following
manner: Status 1 patients were only matched to other sta-
tus 1 patients, and pediatric patients were matched to other
pediatric patients. In addition to matching on MELD score,
patients were also matched on MELD score slope (positive,
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Table 2
Allocation rules used in LSAM runs.a
1999 status-based rules MELD-based rules
Local Local
Status 1 Status 1
Status 2A MELD
Status 2B Regional
Status 3 Status 1
Regional MELD
Status 1 National








a Simulated rules do not include local variances or regional sharing arrange-
ments.
negative, or flat). All runs of the status-based policy used
a single medical status input stream, as did all runs of the
MELD based policy, but replications differed with respect to
Monte Carlo sampling of re-listing probabilities, graft failure
times, and organ acceptance probabilities.
4.3. Policies modeled
Table 2 lists the allocation policies used in the simulation
runs: the 1999 OPTN rule and a hypothesized MELD-based
rule. (The listed rules apply to the allocation of livers from
adult donors. For a liver from a pediatric donor, the poli-
cies further partition each classification into pediatric and
adult candidates, with the pediatric subgroup listed first.) The
MELD-based rule was defined by aggregating the status 2A,
2B, and 3 classifications rule within the local, regional, and
national levels. Status 1 was retained as a separate classifica-
tion, as was the case in the MELD-based policy that was later
initiated by the OPTN on February 27, 2002. The simulation
runs were performed several months prior to this and were not
intended to predict all details of the rule that eventually went
into effect.
For the status-based policy, candidates were ordered within
each classification in decreasing point order, based on the
point award scheme defined in the status-based OPTN policy.
(This includes points for wait time rank and points for identity
or compatibility of blood type.) For the simulated MELD-
based policy, candidates were ordered within each classifica-
tion in decreasing order of waiting time points (for status 1) or
MELD score (for other patients), within geographic distribu-
tion area. Candidates were excluded from the match process
for criteria defined out in the actual status-based OPTN pol-
icy. These criteria were applied to both the MELD-based and
the status-based simulated policies. Rank ordering status 1
patients was based on the same system as the status-based
policy. As noted earlier, not all details of the 2002 OPTN pol-
icy [3] could be anticipated at the time of analysis, but it was
Table 3
Simulated rules versus reality (organs, waitlist, and mortality).
Statistic Study Simulated Simulated




Transplanted organs 4482 4479 4479
Discarded organs 303 309 309
Wait list
Initial waitlist 11,907 11,907 11,907
Patient listings 10,518 10,518 10,518
Removed from waitlist 1504 1499
Relistings 344 303 316
Retransplants 135 125
Final waitlist 14,445 14,806 15,011
Mortality
Total deaths 2355 2114
Wait list deaths 1806 1879 1691
Removed patient deaths 22 25
Relisted patient deaths 60 61
Post-graft deaths 353 394 337
Mortality by status
Status 1 deaths 119 146 151
Status 2A deaths 172 193 362
Status 2B deaths 556 564 393
Status 3 deaths 457 451 306
Inactive status deaths 502 525 479
Unknown status deaths 4
Mortality by meld
MELD 31-40 deaths 700 555
MELD 21-30 deaths 428 306
MELD 11-20 deaths 344 367
MELD 00-12 deaths 407 463
Survival
Post-graft surviving 3782 3826
still possible to simulate a general change to a new system
based that orders candidates on the basis of MELD scores.
4.4. Simulated status-based rules versus reality
Tables 3 and 4 compare the actual experience of the patients
waitlisted in 1999 to the simulated results from LSAM (mean
results of ten replications) using the prioritization for organ al-
location used in 1999, sorted by status within local, regional,
and national. (The number of replications was limited to ten
due to long run times.) These results show good agreement
for most of the criteria shown, subject to random variation.
Extensive sensitivity analyses with various specifications of
the model suggest that the results change in expected direc-
tions when the inputs are changed. The most notable discrep-
ancy for this model is in the waitlist mortality.
The simulated waitlist mortality is higher than was actu-
ally experienced. Changes in the specification of the artifi-
cially generated death dates for those patients who received
a transplant in real life will lead to better agreement between
simulated and actual waitlist mortality. However, it was not
possible to make this adjustment without rebuilding the se-
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Table 4
Simulated rules versus reality (transplants).
Statistic Study Simulated Simulated




Status 1 transplants 551 531 525
Status 2A transplants 931 977 402
Status 2B transplants 2541 2361 1659
Status 3 transplants 442 610 1893
Transplants by meld
MELD 31-40 transplants 629 813
MELD 21-30 transplants 97 388
MELD 11-20 transplants 820 1692
MELD 00-10 transplants 2933 1586
Pediatric transplants
Pediatric transplants 449 525 667
Transplants by location
Local transplants 3298 3615 3592
Regional transplants 887 689 704
National transplants 282 175 183
Transplants in region 01 133 152 155
Transplants in region 02 630 633 641
Transplants in region 03 697 685 681
Transplants in region 04 403 430 435
Transplants in region 05 675 692 688
Transplants in region 06 135 89 89
Transplants in region 07 463 489 496
Transplants in region 08 331 317 314
Transplants in region 09 313 251 247
Transplants in region 10 312 349 346
Transplants in region 11 375 392 387
lected MELD histories for all patients. (Such changes can be
made in the near future. Our flexibility in changing the spec-
ification of the waitlist death rates is currently limited by the
need to concurrently change the simulation of MELD scores
and status changes for the input data files.) Currently, we have
not simulated removal from the waitlist in the artificial patient
histories. Inclusion of these removals will also lead to lower
waitlist mortality.
4.5. Simulated status-based rules versus MELD
Tables 3 and 4 also compare the results of using the 1999
status-based organ allocation rules to the hypothesized MELD
allocation rule. Since it was important to include pediatric
patients in order to make these results comparable to the sta-
tus based results, MELD score histories for pediatric patients
were selected from adult patients in the University of Michi-
gan study of MELD mortality.
The major differences in allocation with these two sets of
rules are as expected. The status based rules lead to more sta-
tus 1 transplants while the MELD based rule leads to more
transplants among patients with high MELD. In addition, the
MELD allocation rules lead to lower death rates on the wait-
list.
Because of a number of differences (details of the MELD
policy and the candidate cohort) exact comparisons to the ac-
tual experience of introducing the MELD policy in February
2002 are not to be expected, but it is interesting to observe the
general level of change that is predicted. Based on prelim-
inary review of outcomes at six months (February 27, 2002
through August 27, 2002), deaths among patients on the wait-
list decreased by 23%, after adjusting for changes in the size
of the waitlist the year before [17]. This compares to a 10%
reduction for the simulated results. When more data from the
actual introduction of a MELD-based rule become available,
the analysis presented here can be repeated with data for the
2002 cohort and with simulated policy approximating that ac-
tually implemented.
5. Conclusion
In its first application, the LSAM prototype was quickly
adapted to support a prospective investigation of the transi-
tion to a new liver allocation policy. The model reproduced
important features of historically observed allocations and
outcomes, and it predicted changes in the directions antici-
pated for a hypothetical policy based on the use of MELD
and PELD scores. Subsequently, LSAM is undergoing fur-
ther review and refinement, and the other simulations, TSAM
and KPSAM, are being readied for analyses of heart, lung,
kidney, and pancreas allocation policies. One of the refine-
ments in development is a facility to generate synthetic data
for patient and organ arrival streams and for patient status his-
tories. This facility will help model users explore a range
of assumptions about the future incidence of end-stage liver
disease and the availability of donor organs, and the implica-
tions of these assumptions for outcomes like life years saved.
The power and flexibility demonstrated in this initial expe-
rience suggest that our modeling approach will prove useful
in analyzing a wide variety of organ allocation policies and
related issues of importance to the transplantation commu-
nity.
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